Entering text into the input field will update the search result below

Signal Genetics reports Q4 results

Mar. 30, 2015 8:38 AM ETViridian Therapeutics, Inc. (VRDN) StockBy: Niloofer Shaikh, SA News Editor
  • Signal Genetics (SGNL): FY2014 EPS of -$3.50.
  • Revenue of $4.32M (flat Y/Y).
  • Press Release

Recommended For You

More Trending News

About VRDN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VRDN--
Viridian Therapeutics, Inc.